Immuneering to Present at the Piper Sandler 37th Annual Healthcare Conference GlobeNewswire November 25, 2025 NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive and helping them thrive, today announced that management will present at the Piper Sandler 37th Annual Healthcare Conference […]

Historic Win for Electrophysiology Reimbursement in Ambulatory Surgery Centers Provides Unique Opportunity for Catheter Precision's LockeT Device GlobeNewswire November 25, 2025 FORT MILL, S.C., Nov. 25, 2025 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (VTAK – NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market today announced

BellRing Brands to Participate in the Morgan Stanley Global Consumer & Retail Conference GlobeNewswire November 25, 2025 ST. LOUIS, Nov. 25, 2025 (GLOBE NEWSWIRE) — BellRing Brands, Inc. (NYSE:BRBR) (“BellRing”), a holding company operating in the global convenient nutrition category, today announced that it will participate in the Morgan Stanley Global Consumer & Retail Conference

First Watch Restaurant Group, Inc. to Participate in Two December Investor Conferences GlobeNewswire November 25, 2025 BRADENTON, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE) — First Watch Restaurant Group, Inc., (Nasdaq: FWRG) (“First Watch” or the “Company”), the leading Daytime Dining concept serving breakfast, brunch and lunch, today announced it will participate in two investor conferences

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in December GlobeNewswire November 25, 2025 NAARDEN, The Netherlands and MIAMI, Nov. 25, 2025 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated

Nuvectis Pharma to Host a Virtual Key Opinion Leader Meeting to Discuss the NXP900 Phase 1b Program in Advanced Solid Tumors, Including the Combination with Osimertinib in NSCLC Event scheduled for Tuesday, December 2nd at 8:00 AM ET GlobeNewswire November 25, 2025 Fort Lee, NJ, Nov. 25, 2025 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ:

Mike Tyson and TerrAscend Team Up To Launch Tyson 2.0 In Maryland And Pennsylvania GlobeNewswire November 25, 2025 TORONTO, Nov. 25, 2025 (GLOBE NEWSWIRE) — TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced an exclusive licensing agreement with Tyson 2.0, the cannabis brand founded by

Canon Medical Systems USA Receives FDA 510(k) Clearance for Alphenix / Evolve Edition with αEvolve Imaging – Debuted at TCT 2025 In-house design and manufacturing of key components, combined with an integrated AI workflow, for a cohesive MRI experience. GlobeNewswire November 25, 2025 Tustin, Ca, Nov. 25, 2025 (GLOBE NEWSWIRE) — Canon Medical Systems USA

Fate Therapeutics to Present at Piper Sandler 37th Annual Healthcare Conference GlobeNewswire November 25, 2025 SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer

DraftKings Launches Spanish-Language Experience for its Online Sportsbook and Casino The launch reaffirms the company's dedication to a customer-first commitment while expanding its reach to a broader audience GlobeNewswire November 25, 2025 BOSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) — DraftKings Inc. (NASDAQ: DKNG) (“DraftKings”) today announced the launch of a Spanish-language experience available within the